Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in Autosomal Dominant Polycystic Kidney Disease (EXPLORE Study)
The EXPLORE Study, sponsored by the University of Colorado, Denver, aims to investigate the effects of daily caloric restriction on kidney function and metabolism in overweight or obese patients with ADPKD. Given the prevalence of ADPKD and the increasing burden of obesity-related complications, successful outcomes could position the intervention as a novel therapeutic approach in managing ADPKD progression. The study's findings may have significant implications for patient management strategies and could attract interest from pharmaceutical companies focusing on metabolic and renal therapies. The competitive landscape includes existing obesity and metabolic syndrome interventions, but the specific focus on ADPKD may provide a unique market niche. Diligence should consider potential partnerships with organizations like the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for funding and support.
Indication: Autosomal Dominant Polycystic Kidney
Modality: behavioral intervention
Target: Kidney oxidative metabolism and insulin sensitivity in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Sponsor: University of Colorado, Denver
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 07, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Kidney oxidative metabolism and insulin sensitivity in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
View original source fields
Condition raw: Autosomal Dominant Polycystic Kidney
Condition normalized: Autosomal Dominant Polycystic Kidney
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Kidney oxidative metabolism and insulin sensitivity in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Target normalized: Kidney oxidative metabolism and insulin sensitivity in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)